Notch signaling in development, tissue homeostasis, and disease

C Siebel, U Lendahl - Physiological reviews, 2017 - journals.physiology.org
Notch signaling is an evolutionarily highly conserved signaling mechanism, but in contrast to
signaling pathways such as Wnt, Sonic Hedgehog, and BMP/TGF-β, Notch signaling occurs …

Notch signaling, hypoxia, and cancer

M Guo, Y Niu, M Xie, X Liu, X Li - Frontiers in Oncology, 2023 - frontiersin.org
Notch signaling is involved in cell fate determination and deregulated in human solid
tumors. Hypoxia is an important feature in many solid tumors, which activates hypoxia …

Cellular and molecular biology of cancer stem cells of hepatocellular carcinoma

KS Jeng, CF Chang, IS Sheen, CJ Jeng… - International journal of …, 2023 - mdpi.com
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death globally. The
cancer stem cells (CSCs) of HCC are responsible for tumor growth, invasion, metastasis …

Notch in fibrosis and as a target of anti-fibrotic therapy

B Hu, SH Phan - Pharmacological research, 2016 - Elsevier
The Notch pathway represents a highly conserved signaling network with essential roles in
regulation of key cellular processes and functions, many of which are critical for …

[HTML][HTML] Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

M Cervello, JA McCubrey, A Cusimano, N Lampiasi… - Oncotarget, 2012 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for 90% of
primary liver cancers. In the last decade it has become one of the most frequently occurring …

[HTML][HTML] The carcinogenic role of the notch signaling pathway in the development of hepatocellular carcinoma

Q Huang, J Li, J Zheng, A Wei - Journal of Cancer, 2019 - ncbi.nlm.nih.gov
The Notch signaling pathway, known to be a highly conserved signaling pathway in
embryonic development and adult tissue homeostasis, participates in cell fate decisions that …

Elucidating the molecular basis of sorafenib resistance in HCC: current findings and future directions

F Fornari, C Giovannini, F Piscaglia… - Journal of …, 2021 - Taylor & Francis
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality
worldwide. Sorafenib is the first multi-tyrosine kinase inhibitor approved for HCC and it has …

[HTML][HTML] Novel therapeutic strategies for targeting liver cancer stem cells

N Oishi, XW Wang - International Journal of Biological Sciences, 2011 - ncbi.nlm.nih.gov
The cancer stem cell (CSC) hypothesis was first proposed over 40 years ago. Advances in
CSC isolation were first achieved in hematological malignancies, with the first CSC …

Molecular bases of the poor response of liver cancer to chemotherapy

JJG Marin, O Briz, E Herraez, E Lozano… - Clinics and Research in …, 2018 - Elsevier
A characteristic shared by most frequent types of primary liver cancer, ie, hepatocellular
carcinoma (HCC) and cholangiocarcinoma (CCA) in adults, and in a lesser extent …

The Role of Notch3 in Cancer

Z Aburjania, S Jang, J Whitt, R Jaskula‐Stzul… - The …, 2018 - academic.oup.com
The Notch family is a highly conserved gene group that regulates cell‐cell interaction,
embryogenesis, and tissue commitment. This review article focuses on the third Notch family …